|
|
Spotlight on Apoptosis |
| Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies |
1 |
| AM Senderowicz
|
|
Abstract
Full Article (PDF)
|
|
Editorial |
| Hypothesis: Phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia |
10 |
| TA McDonald,
NT Holland,
C Skibola,
P Duramad & MT Smith
|
|
Abstract
Full Article (PDF)
|
|
Reviews |
| Molecular signals in anti-apoptotic survival pathways |
21 |
| DM O’Gorman & TG Cotter
|
|
Abstract
Full Article (PDF)
|
|
| Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study |
35 |
| MA Elliott,
GW Dewald,
A Tefferi & CA Hanson
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts |
| Therapy and Competing Risks in Childhood AML |
| Second malignancy after treatment of childhood acute myeloid leukemia |
41 |
| W Leung,
RC Ribeiro,
M Hudson,
X Tong,
DK Srivastava,
JE Rubnitz,
JT Sandlund,
BI Razzouk,
WE Evans & C-H Pui
|
|
Abstract
Full Article (PDF)
|
|
| Prognosis in Childhood AML |
| Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia |
46 |
| MM Bisschop,
T Révész,
M Bierings,
JF van Weerden,
ER van Wering,
K Hählen & A van der Does-van den Berg
|
|
Abstract
Full Article (PDF)
|
|
| Autologous Grafting in Childhood ALL and Long-term Results |
| Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions |
50 |
| A Balduzzi,
G Gaipa,
S Bonanomi,
M Dassi,
P Perseghin,
F Buscemi,
E D’Aniello,
A Rovelli,
R Schirò,
D Longoni,
A Rambaldi,
C Uderzo & A Biondi
|
|
Abstract
Full Article (PDF)
|
|
| Technical Clinical Correlates in Patients with AML1 |
| Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing |
57 |
| JE Sarriera,
M Albitar,
Z Estrov,
C Gidel,
R Aboul-Nasr,
T Manshouri,
S Kornblau,
K-S Chang,
H Kantarjian & E Estey
|
|
Abstract
Full Article (PDF)
|
|
| Progenitors’ Cell Cycle Status in CML |
| Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia |
62 |
| A Krämer,
H Löffler,
J Bergmann,
A Hochhaus & R Hehlmann
|
|
Abstract
Full Article (PDF)
|
|
| Pharmacodynamics and Pharmacogenomics |
| Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells |
69 |
| M Ahlmann,
C Lanvers,
K Lümkemann,
C Rössig,
A Freund,
M Baumann & J Boos
|
|
Abstract
Full Article (PDF)
|
|
| 6-Mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia |
74 |
| K Schmiegelow & U Bretton-Meyer
|
|
Abstract
Full Article (PDF)
|
|
| Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance |
80 |
| M Smeets,
R Raymakers,
P Muus,
G Vierwinden,
P Linssen,
R Masereeuw & T de Witte
|
|
Abstract
Full Article (PDF)
|
|
| Molecular Cytogenetics |
| Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation |
89 |
| I Kitabayashi,
Y Aikawa,
A Yokoyama,
F Hosoda,
M Nagai,
N Kakazu,
T Abe & M Ohki
|
|
Abstract
Full Article (PDF)
|
|
| Detection of E2A translocations in leukemias via fluorescence in situ hybridization |
95 |
| T Boomer,
M Varella-Garcia,
L McGavran,
L Meltesen,
AS Olsen & SP Hunger
|
|
Abstract
Full Article (PDF)
|
|
| Apoptosis and C/EPB in Mice Myeloid Cells |
| C/EBP -/- mice: increased rate of myeloid proliferation and apoptosis |
103 |
| W Verbeek,
M Wächter,
J Lekstrom-Himes & HP Koeffler
|
|
Abstract
Full Article (PDF)
|
|
| Ship in AML and Normal |
| The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro |
112 |
| S Horn,
J Meyer,
J Heukeshoven,
B Fehse,
C Schulze,
S Li,
J Frey,
S Poll,
C Stocking & M Jücker
|
|
Abstract
Full Article (PDF)
|
|
| Immunology |
| Immunoglobulin lambda isotype gene rearrangements in B cell malignancies |
121 |
| T Tümkaya,
M van der Burg,
R Garcia Sanz,
M Gonzalez Diaz,
AW Langerak,
JF San Miguel & JJM van Dongen
|
|
Abstract
Full Article (PDF)
|
|
| HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse |
128 |
| M Wetzler,
MR Baer,
SJ Stewart,
K Donohue,
L Ford,
CC Stewart,
EA Repasky & S Ferrone
|
|
Abstract
Full Article (PDF)
|
|
| Minimal Residual Disease in B-ALL and Clonal Analysis |
| Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy |
134 |
| V de Haas,
OJHM Verhagen,
AEGKr von dem Borne,
W Kroes,
H van den Berg & CE van der Schoot
|
|
Abstract
Full Article (PDF)
|
|
| Cell Line Models for T Leukemia |
| Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice |
141 |
| DS Chervinsky,
DH Lam,
X-F Zhao,
MP Melman & PD Aplan
|
|
Abstract
Full Article (PDF)
|
|
| Lymphoma |
| Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK |
148 |
| Y Kagami,
J Jung,
YS Choi,
K Osumi,
S Nakamura,
Y Morishima & M Seto
|
|
Abstract
Full Article (PDF)
|
|
| Myeloma and Plasma Cell Disease |
| Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia |
157 |
| T Uchida,
T Kinoshita,
T Ohno,
H Ohashi,
H Nagai & H Saito
|
|
Abstract
Full Article (PDF)
|
|
Bio-technical Methods Section (BTS) |
| Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay |
166 |
| X Chen,
Q Pan,
P Stow,
FG Behm,
R Goorha,
C-H Pui & GAM Neale
|
|
Abstract
Full Article (PDF)
|
|
| Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features |
171 |
| M Dominici,
D Campioni,
F Lanza,
M Luppi,
P Barozzi,
S Pauli,
R Milani,
F Cavazzini,
M Punturieri,
R Trovato,
G Torelli & G Castoldi
|
|
Abstract
Full Article (PDF)
|
|
| Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis |
177 |
| A Viardot,
JI Martin-Subero,
R Siebert,
S Harder,
S Gesk,
M Bentz & B Schlegelberger
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| The natural history and clinico-pathological features of the variant form of hairy cell leukemia |
184 |
| E Matutes,
A Wotherspoon,
V Brito-Babapulle & D Catovsky
|
|
Full Article (PDF)
|
|
| Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion |
186 |
| C Rigamonti,
C Volta,
S Colombi,
L Forti,
F Savinelli,
G Gaidano & E Bartoli
|
|
Full Article (PDF)
|
|
| Remission of severe cold agglutinin disease Rituximab therapy |
187 |
| N Layios,
E Van Den Neste,
E Jost,
V Deneys,
JM Scheiff & A Ferrant
|
|
Full Article (PDF)
|
|
| Age cohort subgroups in adult acute myeloid leukaemia studies – the population perspective |
188 |
| SJ Proctor & PRA Taylor
|
|
Full Article (PDF)
|
|
| CD13/aminopeptidase N involvement in dendritic cell maturation |
190 |
| VHJ van der Velden,
PJM Leenen & HA Drexhage
|
|
Full Article (PDF)
|
|
| Deletion of the multidrug resistance protein 1 (MRP1) gene in acute myeloid leukemia patients with inversion 16: expression of MRP1homologues |
191 |
| DM van der Kolk,
EGE de Vries & E Vellenga
|
|
Full Article (PDF)
|
|
| Is HLA-DR4 or the HLA-DRB1*0402 allele associated with decreased risk for CML? |
192 |
| G Pawelec & W Wagner
|
|
Full Article (PDF)
|
|
